Stuart Falber > WilmerHale > Boston, United States > Lawyer Profile
WilmerHale Offices
60 STATE STREET
BOSTON, MA 02109
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Stuart Falber
Work Department
Capital Markets Corporate Governance and Disclosure; Cross-Border Transactions; Emerging Company and Venture Capital; Life Sciences; Mergers and Acquisitions
Position
Partner
Co-Chair, Life Sciences Group
Career
Stuart Falber exclusively represents clients in the life sciences area. For 30 years, Mr. Falber has served as counsel for a broad range of life sciences clients, ranging from startup private companies to mature public companies, investment banks and venture capital funds.
Mr. Falber’s practice focuses on corporate and securities law, with an emphasis on private and public company counseling; representation of issuers, investment banks and investors in venture capital transactions, public offerings and other financing transactions; mergers and acquisitions, including public and private company acquisitions and dispositions, asset acquisitions and sales, and public and private company spinoffs; and corporate collaborations and licensing transactions.
Learn more about Mr. Falber’s practice and how he can support your startup on WilmerHaleLaunch.com.
Professional Activities
Mr. Falber is a member of the American Bar Association, the Massachusetts Bar Association and the Boston Bar Association. He previously served as a member of the Boston Bar Association’s 2017 Life Sciences Conference Advisory Committee.
Memberships
Bar Admissions:
Massachusetts
Other Organizations:
American Bar Association
Boston Bar Association
Education
University of Pennsylvania Law School , J.D. (1990)
Tufts University , B.A. (1987)
Lawyer Rankings
United States > Finance > Capital markets: equity offerings
WilmerHale has a notable record in representing growth companies in IPOs and other equity offerings, particularly those in the life sciences and technology sectors. In 2023, it continued to advise issuers in mid-market public offerings and follow-on offerings, especially those by life sciences issuers. Boston partners Stuart Falber and Cynthia Mazareas are noted for life sciences sector offerings with Lisa Firenze and Brian Johnson being key figures in New York. Caroline Dotolo is another ‘go to‘ partner in Boston.
United States > Healthcare > Life sciences
Pharmaceutical companies, academic institutions and investors come to WilmerHale for advice on critical transactions, including M&A, joint ventures and strategic alliances, in addition to being entrusted with complex patent disputes. Stuart Falber is sought after by a range of established players and new market entrants, including VC investors, for IPOs, spinoffs and licensing deals, leading the team alongside Lisa Pirozzolo, who represents clients in patent infringement and contractual litigation; both are based in Boston. In Washington DC, Amy Wigmore brings further litigious experience, handling a range of matters under the Hatch-Waxman Act and concerning biosimilars. Judith Hasko joined in Palo from Latham & Watkins LLP in June 2024, bringing significant experience.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Antitrust > Cartel
- International trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Industry focus > Education
- Industry focus > Education
- Industry focus > Education
- Intellectual property > Patents: licensing
- Industry focus > Native American law
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Securities litigation: defense
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Outsourcing
- Government > State attorneys general
- Media, technology and telecoms > Technology transactions
- International trade > Trade remedies and trade policy
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Capital markets: equity offerings
- M&A/corporate and commercial > Corporate governance
- International trade > Customs, export controls and economic sanctions
- Government > Government contracts
- Government > Government relations
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (International Trade Commission)
- Tax > US taxes: non-contentious
- Finance > Commercial lending
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Dispute resolution > Corporate investigations and white-collar criminal defense